These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20810373)

  • 1. Randomized controlled trials with statistically nonsignificant results.
    Allison DB; Cope MB
    JAMA; 2010 Sep; 304(9):965; author reply 965. PubMed ID: 20810373
    [No Abstract]   [Full Text] [Related]  

  • 2. Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication.
    Saldanha IJ; Scherer RW; Rodriguez-Barraquer I; Jampel HD; Dickersin K
    Trials; 2016 Apr; 17(1):213. PubMed ID: 27113767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
    Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
    Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industry collaboration and randomized clinical trial design and outcomes.
    Roper N; Zhang N; Korenstein D
    JAMA Intern Med; 2014 Oct; 174(10):1695-6. PubMed ID: 25156272
    [No Abstract]   [Full Text] [Related]  

  • 5. [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?].
    Als-Nielsen BE; Chen W; Gluud CN; Gluud LL
    Ugeskr Laeger; 2004 Apr; 166(18):1676-8. PubMed ID: 15174406
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
    Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
    CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Independent research should be supported].
    Als-Nielsen B; Gluud C; Gluud LL
    Ugeskr Laeger; 2003 Oct; 165(44):4237; author reply 4237-8. PubMed ID: 14621563
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry sponsorship and positive outcome in vascular and endovascular randomised trials.
    Hajibandeh S; Hajibandeh S; Antoniou SA; Antoniou GA; Torella F
    Vasa; 2017 Jan; 46(1):67-68. PubMed ID: 27889961
    [No Abstract]   [Full Text] [Related]  

  • 10. The association between funding by commercial interests and study outcome in randomized controlled drug trials.
    Yaphe J; Edman R; Knishkowy B; Herman J
    Fam Pract; 2001 Dec; 18(6):565-8. PubMed ID: 11739337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
    Hammerschmidt D
    Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
    [No Abstract]   [Full Text] [Related]  

  • 12. Keeping 'em honest: the current crisis of confidence in antidepressants.
    Teboul E
    J Clin Psychiatry; 2011 Jul; 72(7):1015; author reply 1015-6. PubMed ID: 21824461
    [No Abstract]   [Full Text] [Related]  

  • 13. How skeptical should we be about industry-sponsored studies?
    Meador KJ
    Neurology; 2007 Apr; 68(15):1238; author reply 1238. PubMed ID: 17420417
    [No Abstract]   [Full Text] [Related]  

  • 14. Data bases of clinical trials.
    Albrich JM
    N Engl J Med; 1999 Jan; 340(1):65-6. PubMed ID: 9882223
    [No Abstract]   [Full Text] [Related]  

  • 15. Authorship selection in industry-sponsored publications of dermatology clinical trials.
    Tauber M; Paul C
    Br J Dermatol; 2017 Jun; 176(6):1669-1671. PubMed ID: 28303566
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome reporting bias in government-funded RCTs.
    Moja PL; Moschetti I; D'Amico R
    CMAJ; 2005 Mar; 172(7):857; author reply 857. PubMed ID: 15795393
    [No Abstract]   [Full Text] [Related]  

  • 17. The evidence behind our evidence-based decisions: cheques and balances.
    Halkin H
    Isr Med Assoc J; 2006 Jul; 8(7):494-6. PubMed ID: 16889166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Selective reporting--greater problem than selective publishing?].
    Melander H
    Lakartidningen; 2005 Jan 24-30; 102(4):224-5. PubMed ID: 15743133
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized clinical trials: what gets published, and when?
    Hirsch L
    CMAJ; 2004 Feb; 170(4):481-3. PubMed ID: 14970095
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence from randomized controlled trials, meta-analyses, and subgroup analyses.
    Vosk A
    JAMA; 2010 Apr; 303(13):1253; author reply 1254-5. PubMed ID: 20371781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.